Deepaben Bhavsar is an accomplished regulatory affairs professional based in Iselin, New Jersey. With a strong educational foundation, including a Master’s in Project Management from Northeastern University and a Bachelor’s of Pharmacy from Dharamsinh Desai University in India, Deepaben combines academic knowledge with extensive practical experience. Her professional journey has been distinguished by impactful contributions to the pharmaceutical industry, particularly through the preparation and submissions of numerous regulatory submissions focused on rare diseases and accelerated approval pathways aimed at improving patients’ lives. Over the years, she has developed deep expertise in regulatory strategy, compliance, cross-functional collaboration, and submission planning.
Q 1: What motivated you to pursue a career in regulatory affairs, particularly in the pharmaceutical sector?
A: My motivation to pursue a career in regulatory affairs stems from my pharmacy background and a strong desire to work at the intersection of science, healthcare, and policy. I was drawn to the pharmaceutical regulatory space because of its vital role in ensuring that life-changing therapies are both safe and effective before reaching patients. This field offers a unique opportunity to combine scientific expertise with strategic thinking, compliance, and global impact. Over the years, my work especially on Orphan drugs, rare disease programs and accelerated approval pathways has deepened my commitment to regulatory excellence. I find it incredibly fulfilling to help bring innovative treatments to market, knowing that each program and its submission to the FDA contributes to improving and in some cases, saving patients’ lives.
Q 2: How do you approach managing complex regulatory submissions, and what key factors do you consider?
A: My approach to managing complex regulatory submissions is built on strategic foresight, meticulous planning, and seamless cross-functional collaboration. I begin by thoroughly analyzing the regulatory requirements, developing submission strategies that align with agency expectations and the sponsor’s development goals. Key considerations include submission timelines, quality of documentation, relevant regulatory precedents, and identifying potential risks that could impact approval. I place a strong emphasis on building collaborative relationships with internal teams and external stakeholders to ensure the accuracy, compliance, and completeness of the regulatory documents for each submission.
Q 3: Can you describe a challenging regulatory project you managed and how you overcame obstacles?
A: One of the most challenging regulatory projects I managed involved a high-priority submission with exceptionally tight timelines and complex regulatory requirements. We faced unexpected delays due to insufficient data discovered late in the process. Recognizing the organisational pressure, I swiftly assembled a cross-functional task force comprising experts from clinical, CMC, and medical writing teams. I implemented daily progress meetings to ensure alignment, streamlined workflows, and reallocated resources to ensure critical activities remained on track. Throughout the process, I maintained open and transparent communication across all stakeholders. This proactive, solutions-driven approach enabled us to submit on schedule and secure regulatory approval with minimal agency queries. The experience reinforced the importance of agility, collaboration, and strategic leadership in navigating high-stakes regulatory challenges.
Q 4: What role does project management play in your regulatory affairs approach?
A: Project management is foundational to my regulatory affairs approach, enabling me to bring structure, clarity, and efficiency to complex submission processes. I apply project management skills to break down complex submissions into manageable, clearly defined tasks, deliverables, milestones, and timelines. Leveraging tools such as Asana, I actively track progress, assess potential risks, and ensure team accountability throughout the project lifecycle. My project management expertise allows me to anticipate bottlenecks, adapt to changing priorities, and manage resource constraints effectively. This disciplined approach has been critical in overseeing multiple concurrent submissions ranging from Pre-INDs, INDs, to lifecycle management submissions while ensuring on-time submission of high-quality, compliant content under tight and often non-negotiable FDA deadlines. Ultimately, it’s what allows me to lead with confidence and deliver strategic value in fast-paced, high-stakes regulatory environments.
Q 5: How do you incorporate efficiency and quality assurance into your regulatory processes?
A: Efficiency and quality go hand in hand in regulatory operations, and I embed both into every stage of the submission process. I establish standardized workflows, templates, and best practices that not only streamline document preparation, publishing and submission process but also promote consistency across programs. Rather than relying solely on end-stage quality checks of the entire dossier, I take a proactive approach by reviewing each module at a time. This approach reduces rework, enables timely updates to the package, enhances overall accuracy, and ensures that any validation errors are identified and addressed early.
My experience leading regulatory operations teams and working with advanced publishing & document management systems has enabled me to implement automation & digital tools to streamline redundant tasks. This creates more space for the team to focus on strategic elements, such as regulatory interpretation and scientific aspects requiring human judgment. Ultimately, this integrated approach ensures that submissions are both timely and high quality, supporting regulatory success and patient access to critical therapies.
Q 6: What tools or software do you rely on for regulatory document management, and why?
A: I rely on a suite of industry-standard tools to drive efficiency, accuracy, and compliance in regulatory submissions. For document management and version control, tools like Veeva Vault and DocuBridge are instrumental in maintaining structured workflows and ensuring traceability. I use publishing tools such as Lorenz DocuBridge and ARIM to ensure submissions are formatted accurately and placed appropriately within the eCTD structure. To manage timelines and cross-functional tasks, I use project management tools like Asana, which help me track progress, manage dependencies, and stay ahead of deadlines. SharePoint is also a key resource for collaborative document development, especially when coordinating with sponsors and global teams.
Q 7: How do you manage communications with regulatory agencies and ensure effective collaboration?
A: Clear, proactive, and strategic communication with regulatory agencies is essential for program success. I approach agency interactions with thorough preparation, aligning all communications with the overarching regulatory strategy and ensuring consistency across submissions. For FDA meetings, I prepare concise background presentations to clearly communicate the project’s context and objectives. I also organize mock meetings and ad-hoc discussions with internal teams and sponsors to ensure everyone is aligned and well-prepared. During the regulatory review process, I prioritize timely, accurate responses to agency inquiries and maintain professional, collaborative relationships with FDA reviewers. This proactive and strategic communication helps facilitate a smooth review process and supports positive regulatory outcomes. I maintain detailed records of all interactions to preserve institutional knowledge, support future submissions, and ensure continuity across programs.
Q 8: What advice would you give to someone aspiring to enter the regulatory affairs field?
A: My advice would be to build a strong foundation in life sciences, drug development, and regulatory affairs through formal education and continuous learning. It’s important to not only understand regulatory requirements but also grasp the scientific and strategic rationale behind them. Gaining hands-on experience through internships or entry-level positions provides exposure to real-world regulatory processes and submissions. Developing strong communication skills is essential, as the role often requires translating complex regulatory requirements to various stakeholders. I also encourage staying engaged with professional networks and industry groups such as RAPS to remain current with evolving global regulations. Lastly, cultivating a mindset of agility and precision success in regulatory affairs often hinges on being detail-oriented while navigating shifting priorities and timelines.
Q 9: How do you stay current with evolving regulatory requirements and guidelines?
A: I stay current by actively monitoring regulatory agency websites for new guidance documents and updates. I participate in industry conferences and webinars focused on regulatory updates and trends. As an engaged member of professional organizations such as RAPS, I have access to expert analysis and peer discussions that help interpret new requirements in a practical context. I also regularly review FDA guidances and publications to stay informed on industry best practices. Additionally, I maintain connections with a network of regulatory professionals who share insights about changing expectations and precedents. This multi-faceted approach ensures I have both the formal knowledge of new requirements and practical understanding of how they’re being interpreted and implemented.
Q 10: What are your long-term goals in your career, and how do you plan to achieve them?
A: My long-term goal is to become a strategic regulatory leader who can shape organizational approaches to global regulatory challenges while mentoring the next generation of regulatory professionals. I aim to expand my expertise beyond submission management to include more regulatory influence and strategic planning at the enterprise level. To achieve this, I am continuously developing my leadership skills through both formal education and practical experience leading cross-functional teams and managing complex regulatory projects. I’m also broadening my global regulatory knowledge to support global drug development programs. Pursuing advanced certifications in regulatory affairs, complemented by my pharmacy background and project management experience, will further prepare me to take on broader strategic roles in the future.
About Deepaben Bhavsar
Deepaben Bhavsar is a regulatory affairs professional with a passion for bringing safe and effective pharmaceutical products to patients. With a Master’s in Project Management from Northeastern University and a Bachelors of Pharmacy, Deepaben has a proven track record in managing complex regulatory submissions from clinical development through approval. Her expertise includes regulatory strategy, eCTD submissions, labeling, and cross-functional collaboration. With proficiency in numerous regulatory tools and strong organizational skills, Deepaben is dedicated to driving efficiency and compliance in the pharmaceutical regulatory industry.
